• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Xencor Inc (NQ: XNCR )

    16.03 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 16.03
    Bid (Size) 15.87 (10)
    Ask (Size) 16.47 (10)
    Prev. Close 16.03
    Today's Range 16.03 - 16.03
    52wk Range 15.31 - 26.84
    Shares Outstanding 59,924,016
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    XNCR Stock Earnings: Xencor Misses EPS, Beats Revenue for Q2 2024
    XNCR stock results show that Xencor missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Xencor Reports Second Quarter 2024 Financial Results
    From Xencor, Inc.
    Via Business Wire

    Performance

    YTD
    -28.79%
    -28.79%
    1 Month
    -21.54%
    -21.54%
    3 Month
    -28.63%
    -28.63%
    6 Month
    -24.74%
    -24.74%
    1 Year
    -28.98%
    -28.98%

    More News

    Read More
    Decoding 5 Analyst Evaluations For Xencor
    Via Benzinga
    Peeling Back The Layers: Exploring Xencor Through Analyst Insights
    Via Benzinga
    Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
    From Xencor, Inc.
    Via Business Wire
    Decoding 6 Analyst Evaluations For Xencor
    Via Benzinga
    Analyst Scoreboard: 6 Ratings For Xencor
    Via Benzinga
    Unveiling 4 Analyst Insights On Xencor
    Via Benzinga
    XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Xencor Reports First Quarter 2024 Financial Results
    From Xencor, Inc.
    Via Business Wire
    Xencor Appoints Bart Cornelissen as Chief Financial Officer
    From Xencor, Inc.
    Via Business Wire
    Xencor to Present at Upcoming Investor Conferences
    From Xencor, Inc.
    Via Business Wire
    Recap: Xencor Q4 Earnings
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Earnings Preview: Xencor
    Via Benzinga
    Navigating 4 Analyst Ratings For Xencor
    Via Benzinga
    Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
    From Xencor, Inc.
    Via Business Wire
    Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
    From Xencor, Inc.
    Via Business Wire
    Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Xencor, Inc.
    Via Business Wire
    Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
    From Xencor, Inc.
    Via Business Wire
    Preview: Xencor's Earnings
    Via Benzinga
    Xencor Reports Third Quarter 2023 Financial Results
    From Xencor, Inc.
    Via Business Wire
    Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
    From Xencor, Inc.
    Via Business Wire
    Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
    From Xencor, Inc.
    Via Business Wire
    Earnings Scheduled For November 7, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.